Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-31

FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

The FDA approved a supplemental application for alendronate sodium from Amneal Pharmaceuticals of New York LLC for use as a generic product under an abbreviated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

SUPPL AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)